Conference Coverage (ICAAC)

Streptomycin Resistance Not Due to rpsL or rrs Mutations

Published in TB and Outbreaks Week, October 21st, 1996

Resistance to amikacin and streptomycin does not appear to occur from mutations in the "hot-spot" regions of the rpsL gene or the rrs gene, according to a report from Detroit, Michigan's Wayne State University.

The report was presented by researcher J. George and colleagues at the 36th meeting of the American Society for Microbiology's Interscience Conference on Antimicrobial Agents and Chemotherapy, held September 15-18, 1996 in New Orleans, Louisiana.

Streptomycin and other aminoglycosides such as amikacin (AMK) and kanamycin (KAN) are being used more and more frequently in the treatment of multidrug-resistant strains of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1996-10-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry